Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients.

Saved in:
Bibliographic Details
Title: Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients.
Authors: Cannova JM; 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., DuVall AS; 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Kline J; 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Feinberg N; 2Department of Radiology, University of Chicago, Chicago, IL., Wool GD; 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Riedell PA; 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Feb 19; Vol. 24 (3), pp. 128-131. Date of Electronic Publication: 2026 Feb 19.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-1413
DOI:10.6004/jnccn.2025.7119